{"BillId":26592,"BillType":"HB","BillTypeFull":"House Bill","BillNumber":1099,"Title":"reschedule the pharmaceutical composition of crystalline polymorph psilocybin in a drug product approved by the Food and Drug Administration as a Schedule IV controlled substance.","SessionId":71,"BillSponsor":[{"SessionMemberId":4803,"Politics":"R","MemberType":"S","SponsorType":"P","Member":{"FirstName":"Tom","LastName":"Pischke","UniqueName":"Pischke"}},{"SessionMemberId":4808,"Politics":"R","MemberType":"H","SponsorType":"P","Member":{"FirstName":"Taylor","LastName":"Rehfeldt","UniqueName":"Rehfeldt"}},{"SessionMemberId":4743,"Politics":"R","MemberType":"S","SponsorType":"C","Member":{"FirstName":"Sydney","LastName":"Davis","UniqueName":"Davis"}},{"SessionMemberId":4749,"Politics":"D","MemberType":"H","SponsorType":"C","Member":{"FirstName":"Eric","LastName":"Emery","UniqueName":"Emery"}},{"SessionMemberId":4753,"Politics":"R","MemberType":"H","SponsorType":"C","Member":{"FirstName":"Tim","LastName":"Goodwin","UniqueName":"Goodwin"}},{"SessionMemberId":4760,"Politics":"R","MemberType":"H","SponsorType":"C","Member":{"FirstName":"Mellissa","LastName":"Heermann","UniqueName":"Heermann"}},{"SessionMemberId":4789,"Politics":"R","MemberType":"H","SponsorType":"C","Member":{"FirstName":"Scott","LastName":"Moore","UniqueName":"Moore"}},{"SessionMemberId":4791,"Politics":"D","MemberType":"H","SponsorType":"C","Member":{"FirstName":"Erik","LastName":"Muckey","UniqueName":"Muckey"}},{"SessionMemberId":4793,"Politics":"R","MemberType":"H","SponsorType":"C","Member":{"FirstName":"Brian","LastName":"Mulder","UniqueName":"Mulder"}},{"SessionMemberId":4800,"Politics":"R","MemberType":"S","SponsorType":"C","Member":{"FirstName":"Carl","LastName":"Perry","UniqueName":"Perry"}},{"SessionMemberId":4824,"Politics":"D","MemberType":"H","SponsorType":"C","Member":{"FirstName":"Nicole","LastName":"Uhre-Balk","UniqueName":"Uhre-Balk"}},{"SessionMemberId":4837,"Politics":"R","MemberType":"S","SponsorType":"C","Member":{"FirstName":"Brandon","LastName":"Wipf","UniqueName":"Wipf"}},{"SessionMemberId":4834,"Politics":"D","MemberType":"H","SponsorType":"C","Member":{"FirstName":"Kadyn","LastName":"Wittman","UniqueName":"Wittman"}}],"BillCommitteeSponsor":"Representatives <a rel=\"noopener\" href=\"https://sdlegislature.gov/Legislators/Profile/4808/Detail\">Rehfeldt</a> (prime), <a rel=\"noopener\" href=\"https://sdlegislature.gov/Legislators/Profile/4749/Detail\">Emery</a>, <a rel=\"noopener\" href=\"https://sdlegislature.gov/Legislators/Profile/4753/Detail\">Goodwin</a>, <a rel=\"noopener\" href=\"https://sdlegislature.gov/Legislators/Profile/4760/Detail\">Heermann</a>, <a rel=\"noopener\" href=\"https://sdlegislature.gov/Legislators/Profile/4789/Detail\">Moore</a>, <a rel=\"noopener\" href=\"https://sdlegislature.gov/Legislators/Profile/4791/Detail\">Muckey</a>, <a rel=\"noopener\" href=\"https://sdlegislature.gov/Legislators/Profile/4793/Detail\">Mulder</a>, <a rel=\"noopener\" href=\"https://sdlegislature.gov/Legislators/Profile/4824/Detail\">Uhre-Balk</a>, and <a rel=\"noopener\" href=\"https://sdlegislature.gov/Legislators/Profile/4834/Detail\">Wittman</a> and Senators <a rel=\"noopener\" href=\"https://sdlegislature.gov/Legislators/Profile/4803/Detail\">Pischke</a> (prime), <a rel=\"noopener\" href=\"https://sdlegislature.gov/Legislators/Profile/4743/Detail\">Davis</a>, <a rel=\"noopener\" href=\"https://sdlegislature.gov/Legislators/Profile/4800/Detail\">Perry</a>, and <a rel=\"noopener\" href=\"https://sdlegislature.gov/Legislators/Profile/4837/Detail\">Wipf</a>","Keywords":[{"Keyword":"Controlled Substances","KeywordId":7242},{"Keyword":"Public Health and Safety","KeywordId":7403}]}